Issue: February 2021
February 18, 2021
1 min read
Save

UMBRELLA

Issue: February 2021
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Trial Scorecard: UMBRELLA

Risk for implantable cardioverter defibrillator shock therapy and death across disease subtypes.